Inside Precision Medicine August 13, 2024
In a cohort study of over 10,000 participants with and without prior SARS-CoV-2 infection, a handful of routine clinical laboratory tests were unable to provide a reliable biomarker of SARS-CoV-2 infection’s post-acute sequelae (PASC), also known as “long COVID.” The researchers also showed that all 25 tests failed to provide significant differences between patients without prior infection and those who tested positive for SARS-CoV-2 several months earlier. This study emphasizes the importance of a sustained effort to understand the biological basis of long-lasting symptoms following SARS-CoV-2 infection.
What is “long COVID”
PASC is a huge problem in public health, as it has been reported in millions of people around the world. “PASC” is commonly used to describe a broad range...
Today's Sponsors
Today's Sponsor